A Pan-Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor

Figure 3

A log-rank test was conducted for the determination on the significance of the overall survival differences (a), DSS differences (b), DFI differences (c), and PFI distinctions (d) with a threshold of , whose results were presented by the way of Kaplan-Meier survival curves versus the patients’ survival rates of low and high MSH2 expression in tumors.

(a)

(b)

(c)

(d)